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Aging is associated with highly reproducible DNA-
methylation (DNAm) changes at specific sites in the 
genome [1-5]. Various combinations of age-associated 
CpG  dinucleotides  have been  used  for  age-estimation  
 
 















































and the average absolute difference of DNAm-predicted 
and chronological age (∆age) can be less than five years 
[6-8]. While such epigenetic aging signatures are 
usually trained to be as precise as possible, the ∆age can 
partly be attributed to effects of biological aging. 
Recently, it has been demonstrated that ∆age is indicative 



























to  estimate  donor  age.  It  has  been  demonstrated  that  the  difference  between  such  epigenetic  age‐predictions  and 
chronological  age  is  indicative  for  of  all‐cause  mortality  in  later  life.  In  this  study,  we  tested  alternative  epigenetic





e.g.,  at  CpGs  associated with  the  genes  PDE4C  and  CLCN6. Our  results  support  the  notion  that  small  aging  signatures 
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for life expectancy: in four longitudinal cohorts of older 
people, accelerated epigenetic aging was associated 
with higher all-cause mortality [9]. That study utilized 
two independent aging signatures: a predictor by 
Hannum and coworkers [6] based on 71 CpGs, and an 
“epigenetic clock” by Horvath that utilizes 353 CpGs 
[7]. However, using our previously described model 
based on three CpG sites (associated with genes ASPA, 
ITGA2B and PDE4C) [8] there was no clear correlation 
with chronological age and therefore this 3-CpG model 
was not further considered [9].  
 
Simple aging signatures - based on few or even 
individual CpGs - facilitate site-specific analysis with 
more quantitative methods without need of profiling 
technology. When we apply the 3-CpG model on 
pyrosequencing data of blood samples the median ∆age 
is usually about 5 years [8,10]. The discrepancy to the 
above mentioned study [9] can partly be attributed to 
the fact that the 3-CpG model was not trained on 
Illumina HumanMethylation450 BeadChip data and that 
it involves a neighbouring CpG site not measured by 
these microarrays. Therefore, we have now adjusted the 
3-CpG model to Illumina HumanMethylation450 
BeadChip data to test it again on the dataset of the 
Lothian Birth Cohort 1921 study (LBC1921). If such 
concise age-predictors are associated with life 
expectancy, they might provide convenient and cost-
























RESULTS AND DISCUSSION 
 
Epigenetic aging-signatures are more robust if 
considering more CpGs 
 
For an independent aging-signature based on multiple 
CpGs we used our previously described model based on 
99 age-associated CpGs (99-CpG model; Figure 1A) 
[8,11]. This model was initially derived from 
HumanMethylation27 BeadChip data [8] and 
subsequently trained on 656 DNAm profiles of blood 
samples [6]. The coefficients for this model are 
provided in Supplementary Table 1. To estimate the 
validity of this model, we have tested over ~2,100 
DNAm profiles from 12 additional studies 
(Supplementary Table 2): overall, there was a high 
correlation of predicted and chronological age (Pearson 
correlation R = 0.97; median error = 3.45 years; Figure 
1B). Thus, this relatively large signature of 99 CpGs 
can be applied to DNAm profiles without need of an 
additional normalization regimen.  
 
Similarly, we compared the performance of our 3-CpG 
model [8] - as an example for a simple age-predictor - 
on independent microarray datasets. This model was 
initially trained on pyrosequencing data and it was 
therefore retrained on the above mentioned dataset of 
656 DNAm profiles [6]. Thereby, we derived the 
following multivariate 3-CpG model for Illumina 




























Lothian Birth Cohorts LBC1921 LBC1936 
N 446 920 
n (death) 328 135 
Age (years ± S.D.) 79.1 ± 0.6 69.5 ± 0.8 
Sex (male) 176 (40%) 465 (51%) 
99CpG DNAm Age (years ± S.D.) 76.6 ± 8.8 66.4 ± 9.4 
99CpG Δage (years ± S.D.) -2.5 ± 8.8 -3.2 ± 9.1 
99CpG median error (years) 5.3 5.4 
99CpG Δage HR [95% CI] 1.11 [1.04,1.19] 1.02 [0.93,1.14] 
3CpG DNAm Age (years ± S.D.) 68.4 ± 9.9 61.2 ± 8.9 
3CpG Δage (years ± S.D.) -10.7 ± 10 -8.3 ± 9.0 
3CpG median error (years) 11.5 8.6 
3CpG Δage HR [95% CI] 1.01 [0.96,1.08] 1.02 [0.92,1.13] 
  















































































































Figure 1. Epigenetic age‐predictions  correlate with mortality.  (A)  Scheme  for  the  study design.  Epigenetic  age was estimated
based  on  our  previously  published models with  99  CpGs,  3  CpGs,  or  individual  CpGs  thereof  [8].  The  offset  of  predicted  age  and
chronological age was subsequently correlated with all‐cause mortality in the Lothian Birth Cohort 1921 (LBC1921) and LBC1936. (B) The
99‐CpG model  and  (C)  the  3‐CpG model were  specifically  trained  for  Illumina  HumanMethylation450  BeadChip  data  using  Hannum
dataset (GSE40279) and subsequently validated using additional 12 DNAm datasets of blood samples. (D) The 99‐CpG model was then
applied on DNAm profiles of  LBC1921  and  the deviation of predicted  and  chronological  age  (Δage) was determined  for  each  sample.
Samples in the lowest (Q1) and highest quartiles (Q4) of Δage are depicted in navy and red, respectively. (E) Kaplan‐Meier plots (K‐M) of
LBC1921 participants classified by respective quartiles indicate lower mortality for those with increased Δage.. (F, G) In analogy the same
analysis was performed  for  the  3‐CpG model, but  there was no  significant  association between  these  age‐predictions  and mortality.
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Predicted age (in years) = 111.83 - 64.57[β-value 
cg02228185] - 42.57 [β-value cg25809905] + 75.15 [β-
value cg17861230].  
 
In the validation set of ~2,100 DNAm profiles the 
correlation with chronological age was R = 0.79 and 
median error was 10.9 years (Figure 1C). Thus, the 
precision of this adjusted 3-CpG model is better than 
before [9], but still not in the range of predictions for 
pyrosequencing data (median ∆age ≈ 5 years). Notably, 
samples of younger donors were more likely to be 
overestimated in their epigenetic age. This might be 
partly attributed to the fact that the training datasets did 
not comprise samples of children. Furthermore, it has 
been demonstrated that many DNAm changes are not 
linearly acquired over childhood [12]. DNAm patterns 
vary between cell types and therefore blood counts may 
affect age-predictions – albeit we have previously 
demonstrated that the composition of different blood 
cell types has relatively little impact on predictions by 
our 3-CpG model [8]. Accuracy can be improved by 
using additional CpGs (Supplementary Figure 1). 
Another possibility is to normalize the DNAm profiles – 
but this would again necessitate DNAm levels of a 
multitude of additional CpGs.  
 
Advantages of age-predictors based on few or 
individual CpGs are that (i) they can be measured site-
specifically with quantitative and cost-effective 
methods, (ii) they can be applied with less bioinformatic 
knowledge, and (iii) they are independent from specific 
microarray platforms. The importance of the latter 
becomes evident by the fact that Illumina has recently 
announced to replace the HumanMethylation450 
BeadChip with a new platform. On the other hand, our 
analysis exemplarily demonstrates that age-predictors 
based on few CpGs are less precise in cross-comparison 
of different studies if applied to β-values of microarray 
data. Although simple age-predictors reveal higher 
deviation of chronological age in microarray data, their 
∆age might still be indicative for overall survival. 
 
∆age is indicative for life expectancy 
 
The 99-CpG model and the adjusted 3-CpG model were 
subsequently applied to DNAm profiles of the 
LBC1921 study [9,13]. These participants were born in 
1921 and recruited and tested in older age between 1999 
and 2001 (N = 446; ndeath = 328). The 99-CpG model 
and 3-CpG model revealed median error of 5.3 and 11.5 
years, respectively (Table 1) – whereas it was 5.5 and 
6.0 years using the age-predictors by Hannum et al. or 
Horvath [9]. In the 99-CpG model, a five-year higher 
age-prediction was associated with 11% greater 
mortality risk (95% confidence interval: [1.04, 1.19]; 
Cox regression P = 0.003) after adjustment for gender 
and chronological age. Kaplan-Meier (K-M) analysis of 
quartiles with highest and lowest ∆age (P = 0.0032) 
further visualized and validated that epigenetic-age 
predictions are indicative for all-cause mortality (Figure 
1D,E). 
 
When we used the 3-CpG signature this association was 
not significant (Hazard ratio [95% CI] of Cox 
regression: 1.02 [0.93,1.14]); Figure 1F,G). This might 
be due to the higher offset in age-predictions. Overall, 
the LBC1921 samples were underestimated in their 
epigenetic age and the median error was relatively high. 
It is also conceivable that some age-associated CpGs 
reflect life expectancy better than others. Therefore, we 
trained linear models for each of the three age-
associated CpGs individually and tested association of 
their ∆age with life-expectancy. For the CpG associated 
with the phosphodiesterase 4C (PDE4C; cg17861230) 
we found a significant association with overall survival 
(HR = 1.08 [1.01; 1.17]; Cox P = 0.026; Figure 1H,I) 
but not for the other two CpGs. Subsequently, we tested 
all individual CpGs of the three larger signatures: our 
99-CpG model, the age-predictor by Hannum et al. [6], 
and of Horvath [7]. Although, the underlying algorithms 
are based on the combinatorial effect of multiple age-
associated CpGs, we identified 5 (of 99), 10 (of 71), and 
0 (of 353) significant CpGs, which are highly associated 
with mortality, respectively (Cox P < 0.05, multiple 
correction testing by the Benjamini-Hochberg 
procedure; Supplementary Tables 3-5). 
 
Comparisons in LBC1921 and LBC1936 
 
To further validate mortality-association of these CpGs 
we used DNAm profiles of the first wave in the Lothian 
Birth Cohort 1936 study (LBC1936). These participants 
were analyzed at an average age of 70 years (N = 920; 
ndeath = 135). However, neither the 99-CpG model nor 
the 3-CpG model revealed significant association with 
mortality, which might be due to the relatively low 
number of deaths in this cohort (Table 1). On the other 
hand, age-predictions by the models of Hannum and 
coworkers and of Horvath have previously been 
demonstrated to be indicative for all-cause mortality in 
the LBC1936 dataset [9].  
 
Subsequently, we tested for associations of single-CpG 
derived age-predictions with mortality: several CpGs 
revealed significant results in the LBC1936 data but 
there was only a moderate overlap with survival-
associated CpGs in LBC1921 (Supplementary Tables 3-
5). For example, the CpG site located in PDE4C 
(cg17861230) revealed a similar trend but the results 
were not significant (HR = 1.09 [0.98; 1.21]; Cox P = 
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0.12; Supplementary Figure 2). It might be expected 
that DNAm changes at these CpGs are not entirely 
linear over time and hence they may have different 
prognostic value in cohorts of different age. 
 
Only one of the tested CpG sites (from the 99-CpG 
model) revealed significant association with survival in 
the LBC1921 and LBC1936 datasets. It was associated 
with the gene for the chloride transport protein 6 
(CLCN6; cg05228408) and we observed significant 
association in LBC1921 (HR = 1.16 [1.06,1.26]; Cox P = 
0.00072) and LBC1936 (HR = 1.26 [1.12,1.42]; Cox P = 
0.00013) after multiple correction and adjustment for age 
and gender in each cohort (Figure 2). Notably, several 








































vicinity to this location that are associated with blood 
pressure and hypertension [14-16]. Furthermore, a 
genome-wide association study in rats supported the 
notion that multiple modifiers of hypertension co-
segregate at this locus [17]. We have checked in both 
LBC cohorts if DNAm at CLCN6 is directly associated 
with hypertension, but the correlation with systolic and 
diastolic blood pressure was low (Spearman correlation: 
R = -0.022 and 0.013, respectively). Other parameters, 
such as specific drugs, smoking, and alcohol intake might 
also affect DNAm. Either way, β-values at this age-
associated CpG seem to be associated with life 
expectancy – this should be validated by site-specific 
analysis (e.g. by pyrosequencing of bisulfite converted 










































Figure 2. A CpG site  in CLCN6  is  indicative for survival  in LBC1921 and LBC1936.  (A) A
CpG site associated with the gene for the chloride transport protein 6 (CLCN6; cg05228408) was
used to estimate age in the LBC1921 cohort. (B) Participants in the lowest and highest quartiles of
Δage were  subsequently  analysed  in  Kaplan‐Meier  plots  (K‐M). Hazard  ratio  and  cox‐regression
analysis of  survival were  subsequently  tested with adjustment  for chorological age and gender.
(C, D) In analogy, the same analysis was performed for this CpG site using the LBC1936 cohort. 
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Conclusions 
 
This follow-up study further substantiates the notion 
that epigenetic age-predictions are indicative for 
biological rather than chronological age [9,18]. Similar 
findings have recently been described in a longitudinal 
Danish twin study [19]. We demonstrated that the error 
of age-predictions can be improved for the 3-CpG 
model by training on HumanMethylation450 BeadChip 
data. However, without additional normalization 
regimen, such small aging signatures are not reliable for 
microarray data – they should rather be addressed by 
more quantitative methods for site-specific analysis 
such as pyrosequencing or MassARRAY. On the other 
hand, we demonstrate that even β-values at individual 
age-associated CpGs seem to be indicative for life 
expectancy.  
 
Microarray data of genome wide DNAm profiles of 
large cohort studies resemble a valuable resource to 
correlate DNAm patterns with clinical parameters – 
however, if there is a systematic off-set in epigenetic 
age-predictions, resulting in a different slope in 
comparisons of predicted and chronological ages, then 
this will falsify association with life-expectancy, 
because the percentage of elderly patients that are 
predicted to be older than their chronological age is 
affected. Such a confounding factor is particularly 
relevant for the small aging-signatures that are generally 
more likely to reveal offsets in other microarray datasets 
– but it was hardly relevant in our exemplary analysis, 
as we only considered the first waves of the LBC1921 
and LBC1936 datasets with well-defined donor ages 
close to 79 and 70 years, respectively. To ultimately 
validate the association of simple epigenetic biomarkers 
with biological age, it will be necessary to utilize site-
specific methods for DNAm analysis – so far DNAm 
results by pyrosequencing are not available for large 
cohorts with adequate information on life-expectancy 
and other clinical parameters. Our study provides the 
research perspective that site-specific analysis of 
individual age-associated CpG sites can facilitate cost-
effective high throughput analysis to better discern 
environmental or genetic risk factors to improve the 




The Lothian Birth Cohorts. The Lothian Birth Cohorts 
of 1921 and 1936 are follow-up studies of the Scottish 
Mental Surveys of 1932 and 1947 – for participants 
born in 1921 and 1936, respectively. These nationwide 
studies were initially set up to study determinants of 
non-pathological cognitive ageing [13]. The LBC1921 
and LBC1936 studies attempted to follow-up 
individuals in the Lothian region (Edinburgh and its 
surrounding areas of Scotland) at about the age of 79 
years and 70 years, respectively. There have been 
various additional follow up waves at higher ages but 
we restricted our analysis to the first waves to facilitate 
better comparison with the previous analysis [9] and to 
exclude effects that might be caused by offsets in the 
regression of age-predictions or by repeated analysis of 
the same individuals.  
 
Ethics and data deposition. Ethics permission for 
LBC1921 was obtained from the Lothian Research 
Ethics Committee (Wave 1: LREC/1998/4/183) and for 
LBC1936 from the Multi-Centre Research Ethics 
Committee for Scotland (Wave 1: MREC/01/0/56). 
Written informed consent was obtained from all 
subjects. The data have been deposited at the European 
Genomephenome Archive (EGA; www.ebi.ac.uk/ega/ 
home) under the accession number EGAS00001000910. 
 
DNA methylation of LBC cohorts. The DNAm data 
were processed as previously described [9]. Briefly, raw 
DNAm data of LBC cohort (LBC1921 N = 514; 
LBC1936 N = 1,004) were background corrected and 
converted to methylation β-values using the R minfi 
package (β-values range between 0 and 1 and roughly 
correspond to 0% and 100% DNAm level, 
respectively). The probes with a low (<95%) detection 
rate at P <0.01 were removed from further analysis. In 
addition, manual inspection of the array control probe 
signals was used to identify and remove low quality 
samples, resulting two high quality datasets for aging 
prediction (LBC1921: N = 443; LBC1936: N = 920; all 
samples are from first wave). 
 
Derivation of age predictors. Our 99-CpG model and 
our 3-CpG model for epigenetic age-predictions was 
initially derived from 102 CpGs that revealed linear 
age-associated changes in 575 DNAm profiles of blood 
that were generated on Illumina HumanMethylation27 
BeadChips (Pearson correlation R > 0.85 or R < -0.85; 
age range 0 to 78 years) [8]. Ninety-nine of these CpGs 
are also represented on the Illumina Human-
Methylation450 BeadChips. Derivation of the 99-CpG 
model has been described in detail before [8,11] and the 
coefficients are provided in Supplementary Table 1. The 
3-CpG model was based on β-values of the CpG sites 
cg02228185 (ASPA), cg25809905 (ITGA2B), and 
cg17861230 (PDE4C). It was retrained on the 656 
DNAm profiles of blood samples of Hannum and 
coworkers (age range 19 to 101) [6] using leave-one-out 
cross validation. Age predictors based on individual 
CpGs were also trained on the dataset by Hannum et al. 
using leave-one-out cross validation. Please note that 
using β-values of the corresponding CpGs would have 
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provided similar results as the participants of the waves 
1 were all of similar age. The analysis were performed 
using R [20] and ‘caret’ package [21]. 
 
Training and validation of the epigenetic age-predictors. 
To validate the 99-CpG and 3-CpG model (trained 
using dataset by Hannum et al. [6]; GSE40279) we used 
12 additional publically available DNAm datasets of 
blood that were retrieved from NCBI GEO: GSE30870 
[22], GSE32148 [23], GSE36064 [12], GSE40005, 
GSE41169 [24], GSE42861 [25], GSE50660 [26], 
GSE56105 [27], GSE56581 [28], GSE58651 [29], 
GSE61496 [30] and GSE62924 [31] (Supplementary 
Table 2). These validation datasets were all generated 
using Illumina HumanMethylation450 BeadChip. 
 
Survival analysis. The association of ∆age and mortality 
was tested using cox proportional hazard regression 
models, adjusting for age and gender. The deaths within 
the first 2 years of follow-up were excluded to minimize 
the potential influences of acute illness when cox 
regression analysis is applied for the ∆age of 99-CpG and 
3-CpG models [9]. Hazard ratios for ∆age were 
expressed per 5 years of methylation age acceleration as 
previously described [9]. For Kaplan-Meier (K-M) 
estimation of mortality samples were stratified by first 
and forth quantile of ∆age adjusting for age and gender. 
The analysis were performed using R and ‘survival’ 
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